Posts Tagged ‘stock’
Market Watch for Generex Biotechnology Corp. Issued by StockPreacher (GlobeNewswire via Yahoo! Finance)
12 Mar 2010DALLAS — StockPreacher.com announces an investment report featuring Generex Biotechnology Corp. . The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Shares of this biotechnology firm have rebounded nicely from post-earnings weakness. March 10th, 2010 by admin Leave a reply ».
- No Comments
- Tags: corp-, degree-or-graduate, early-trading, green, laboratories, leave, salt, since-the, stock, you-haven
Shares of BioMarin Pharmaceutical Inc. fell Monday after a Brean Murray analyst downgraded the stock citing its value and a lack of detail on the biotechnology company’s midstage drug programs.
About Biolexis
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.
Biotech
Categories
- Biotechnology News (1243)
Archives
- FDA wants more information on Afrezza (AP via Yahoo! Finance)
- MannKind’s Insulin Afrezza Fails to Win Approval (Update4) (Bloomberg)
- Biotechnology Program Aims to Triple Enrollment in Bay Area, Expanding Opportunities for High School Girls (PR Newswire via Yahoo! Finance)
- Syngenta Adapts High-Volume Genotyping Technology for Agricultural Biotechnology (AgWeb.com)
- Cubist Pharmaceuticals President and CEO Michael Bonney Honored by Massachusetts Biotechnology Council with its 2010 … (Business Wire via Yahoo! Finance)
- Boston Scientific sinks on FDA review foulup (CNN Money)
- India US set to boost high technology trade (Hindustan Times)
- Locals weigh in on possible ag cuts (Elko Daily Free Press)
- Biotechnology Stocks With Bullish Prospects (TheStreet.com)
- Ipsen inks license pact with Rhythm Pharma for 2 programmes in metabolic disorders (PharmaBiz)
